Global Pembrolizumab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pembrolizumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pembrolizumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pembrolizumab by Country/Region, 2017, 2022 & 2028

2.2 Pembrolizumab Segment by Type

2.2.1 50mg Injection

2.2.2 100mg Injection

2.3 Pembrolizumab Sales by Type

2.3.1 Global Pembrolizumab Sales Market Share by Type (2017-2022)

2.3.2 Global Pembrolizumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pembrolizumab Sale Price by Type (2017-2022)

2.4 Pembrolizumab Segment by Application

2.4.1 Advanced Melanoma

2.4.2 Head and Neck Squamous Cell Carcinoma (HNSCC)

2.4.3 Unresectable or Metastatic Solid Tumor

2.4.4 Other

2.5 Pembrolizumab Sales by Application

2.5.1 Global Pembrolizumab Sale Market Share by Application (2017-2022)

2.5.2 Global Pembrolizumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pembrolizumab Sale Price by Application (2017-2022)

3 Global Pembrolizumab by Company

3.1 Global Pembrolizumab Breakdown Data by Company

3.1.1 Global Pembrolizumab Annual Sales by Company (2020-2022)

3.1.2 Global Pembrolizumab Sales Market Share by Company (2020-2022)

3.2 Global Pembrolizumab Annual Revenue by Company (2020-2022)

3.2.1 Global Pembrolizumab Revenue by Company (2020-2022)

3.2.2 Global Pembrolizumab Revenue Market Share by Company (2020-2022)

3.3 Global Pembrolizumab Sale Price by Company

3.4 Key Manufacturers Pembrolizumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pembrolizumab Product Location Distribution

3.4.2 Players Pembrolizumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pembrolizumab by Geographic Region

4.1 World Historic Pembrolizumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Pembrolizumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pembrolizumab Annual Revenue by Geographic Region

4.2 World Historic Pembrolizumab Market Size by Country/Region (2017-2022)

4.2.1 Global Pembrolizumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pembrolizumab Annual Revenue by Country/Region

4.3 Americas Pembrolizumab Sales Growth

4.4 APAC Pembrolizumab Sales Growth

4.5 Europe Pembrolizumab Sales Growth

4.6 Middle East & Africa Pembrolizumab Sales Growth

5 Americas

5.1 Americas Pembrolizumab Sales by Country

5.1.1 Americas Pembrolizumab Sales by Country (2017-2022)

5.1.2 Americas Pembrolizumab Revenue by Country (2017-2022)

5.2 Americas Pembrolizumab Sales by Type

5.3 Americas Pembrolizumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pembrolizumab Sales by Region

6.1.1 APAC Pembrolizumab Sales by Region (2017-2022)

6.1.2 APAC Pembrolizumab Revenue by Region (2017-2022)

6.2 APAC Pembrolizumab Sales by Type

6.3 APAC Pembrolizumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pembrolizumab by Country

7.1.1 Europe Pembrolizumab Sales by Country (2017-2022)

7.1.2 Europe Pembrolizumab Revenue by Country (2017-2022)

7.2 Europe Pembrolizumab Sales by Type

7.3 Europe Pembrolizumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pembrolizumab by Country

8.1.1 Middle East & Africa Pembrolizumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pembrolizumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Pembrolizumab Sales by Type

8.3 Middle East & Africa Pembrolizumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pembrolizumab

10.3 Manufacturing Process Analysis of Pembrolizumab

10.4 Industry Chain Structure of Pembrolizumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pembrolizumab Distributors

11.3 Pembrolizumab Customer

12 World Forecast Review for Pembrolizumab by Geographic Region

12.1 Global Pembrolizumab Market Size Forecast by Region

12.1.1 Global Pembrolizumab Forecast by Region (2023-2028)

12.1.2 Global Pembrolizumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pembrolizumab Forecast by Type

12.7 Global Pembrolizumab Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Pembrolizumab Product Offered

13.1.3 Merck Pembrolizumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

14 Research Findings and Conclusion

Table 1. Pembrolizumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pembrolizumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 50mg Injection

Table 4. Major Players of 100mg Injection

Table 5. Global Pembrolizumab Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Pembrolizumab Sales Market Share by Type (2017-2022)

Table 7. Global Pembrolizumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Pembrolizumab Revenue Market Share by Type (2017-2022)

Table 9. Global Pembrolizumab Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Pembrolizumab Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Pembrolizumab Sales Market Share by Application (2017-2022)

Table 12. Global Pembrolizumab Revenue by Application (2017-2022)

Table 13. Global Pembrolizumab Revenue Market Share by Application (2017-2022)

Table 14. Global Pembrolizumab Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Pembrolizumab Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Pembrolizumab Sales Market Share by Company (2020-2022)

Table 17. Global Pembrolizumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Pembrolizumab Revenue Market Share by Company (2020-2022)

Table 19. Global Pembrolizumab Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Pembrolizumab Producing Area Distribution and Sales Area

Table 21. Players Pembrolizumab Products Offered

Table 22. Pembrolizumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Pembrolizumab Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Pembrolizumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Pembrolizumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Pembrolizumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Pembrolizumab Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Pembrolizumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Pembrolizumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Pembrolizumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Pembrolizumab Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Pembrolizumab Sales Market Share by Country (2017-2022)

Table 35. Americas Pembrolizumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Pembrolizumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Pembrolizumab Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Pembrolizumab Sales Market Share by Type (2017-2022)

Table 39. Americas Pembrolizumab Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Pembrolizumab Sales Market Share by Application (2017-2022)

Table 41. APAC Pembrolizumab Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Pembrolizumab Sales Market Share by Region (2017-2022)

Table 43. APAC Pembrolizumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Pembrolizumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Pembrolizumab Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Pembrolizumab Sales Market Share by Type (2017-2022)

Table 47. APAC Pembrolizumab Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Pembrolizumab Sales Market Share by Application (2017-2022)

Table 49. Europe Pembrolizumab Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Pembrolizumab Sales Market Share by Country (2017-2022)

Table 51. Europe Pembrolizumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Pembrolizumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Pembrolizumab Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Pembrolizumab Sales Market Share by Type (2017-2022)

Table 55. Europe Pembrolizumab Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Pembrolizumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Pembrolizumab Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Pembrolizumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Pembrolizumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Pembrolizumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Pembrolizumab Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Pembrolizumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Pembrolizumab Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Pembrolizumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Pembrolizumab

Table 66. Key Market Challenges & Risks of Pembrolizumab

Table 67. Key Industry Trends of Pembrolizumab

Table 68. Pembrolizumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Pembrolizumab Distributors List

Table 71. Pembrolizumab Customer List

Table 72. Global Pembrolizumab Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Pembrolizumab Sales Market Forecast by Region

Table 74. Global Pembrolizumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Pembrolizumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Pembrolizumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Pembrolizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Pembrolizumab Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Pembrolizumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Pembrolizumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Pembrolizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Pembrolizumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Pembrolizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Pembrolizumab Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Pembrolizumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Pembrolizumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Pembrolizumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Pembrolizumab Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Pembrolizumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Pembrolizumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Pembrolizumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Pembrolizumab Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Pembrolizumab Product Offered

Table 94. Merck Pembrolizumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

List of Figures

Figure 1. Picture of Pembrolizumab

Figure 2. Pembrolizumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pembrolizumab Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Pembrolizumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pembrolizumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 50mg Injection

Figure 10. Product Picture of 100mg Injection

Figure 11. Global Pembrolizumab Sales Market Share by Type in 2021

Figure 12. Global Pembrolizumab Revenue Market Share by Type (2017-2022)

Figure 13. Pembrolizumab Consumed in Advanced Melanoma

Figure 14. Global Pembrolizumab Market: Advanced Melanoma (2017-2022) & (K Pcs)

Figure 15. Pembrolizumab Consumed in Head and Neck Squamous Cell Carcinoma (HNSCC)

Figure 16. Global Pembrolizumab Market: Head and Neck Squamous Cell Carcinoma (HNSCC) (2017-2022) & (K Pcs)

Figure 17. Pembrolizumab Consumed in Unresectable or Metastatic Solid Tumor

Figure 18. Global Pembrolizumab Market: Unresectable or Metastatic Solid Tumor (2017-2022) & (K Pcs)

Figure 19. Pembrolizumab Consumed in Other

Figure 20. Global Pembrolizumab Market: Other (2017-2022) & (K Pcs)

Figure 21. Global Pembrolizumab Sales Market Share by Application (2017-2022)

Figure 22. Global Pembrolizumab Revenue Market Share by Application in 2021

Figure 23. Pembrolizumab Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Pembrolizumab Revenue Market Share by Company in 2021

Figure 25. Global Pembrolizumab Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Pembrolizumab Revenue Market Share by Geographic Region in 2021

Figure 27. Global Pembrolizumab Sales Market Share by Region (2017-2022)

Figure 28. Global Pembrolizumab Revenue Market Share by Country/Region in 2021

Figure 29. Americas Pembrolizumab Sales 2017-2022 (K Pcs)

Figure 30. Americas Pembrolizumab Revenue 2017-2022 ($ Millions)

Figure 31. APAC Pembrolizumab Sales 2017-2022 (K Pcs)

Figure 32. APAC Pembrolizumab Revenue 2017-2022 ($ Millions)

Figure 33. Europe Pembrolizumab Sales 2017-2022 (K Pcs)

Figure 34. Europe Pembrolizumab Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Pembrolizumab Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Pembrolizumab Revenue 2017-2022 ($ Millions)

Figure 37. Americas Pembrolizumab Sales Market Share by Country in 2021

Figure 38. Americas Pembrolizumab Revenue Market Share by Country in 2021

Figure 39. United States Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Pembrolizumab Sales Market Share by Region in 2021

Figure 44. APAC Pembrolizumab Revenue Market Share by Regions in 2021

Figure 45. China Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Pembrolizumab Sales Market Share by Country in 2021

Figure 52. Europe Pembrolizumab Revenue Market Share by Country in 2021

Figure 53. Germany Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Pembrolizumab Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Pembrolizumab Revenue Market Share by Country in 2021

Figure 60. Egypt Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Pembrolizumab Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Pembrolizumab in 2021

Figure 66. Manufacturing Process Analysis of Pembrolizumab

Figure 67. Industry Chain Structure of Pembrolizumab

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles